Ming-Shyue Lee, Ph.D.
Affiliations: | 2002 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Molecular Biology, Biochemistry, OncologyGoogle:
"Ming-Shyue Lee"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ming-Fong Lin | grad student | 2002 | University of Nebraska Medical Center | |
| (ErbB-2 signaling in human prostate cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huang HP, Chen CH, Chang KH, et al. (2023) Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study. Journal of Translational Medicine. 21: 714 |
| Cho CC, Lin CJ, Huang HH, et al. (2023) Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth. Acs Chemical Biology |
| Lin HY, Ko CJ, Lo TY, et al. (2022) Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis. Oncogene |
| Lee CF, Chen YA, Hernandez E, et al. (2022) The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC. Clinical and Translational Medicine. 12: e695 |
| Ko CJ, Hsu TW, Wu SR, et al. (2020) Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis. Oncogene |
| Wu SR, Teng CH, Tu YT, et al. (2020) Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells. Scientific Reports. 10: 2874 |
| Lee CF, Dang A, Hernandez E, et al. (2019) Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase. Oncogene |
| Wu SR, Lin CH, Shih HP, et al. (2019) HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis. British Journal of Cancer |
| Yu CH, Chou CC, Tu HF, et al. (2018) Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase. Oncotarget. 9: 21512-21529 |
| Wu SR, Teng CH, Tu YT, et al. (2017) The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells. Scientific Reports. 7: 15101 |